<SEC-DOCUMENT>0002013681-25-000001.txt : 20250903
<SEC-HEADER>0002013681-25-000001.hdr.sgml : 20250903
<ACCEPTANCE-DATETIME>20250903150541
ACCESSION NUMBER:		0002013681-25-000001
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250903
DATE AS OF CHANGE:		20250903

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BridgeBio Oncology Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001869105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94447
		FILM NUMBER:		251289114

	BUSINESS ADDRESS:	
		STREET 1:		256 E. GRAND AVENUE, SUITE 104
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		857 702 0377

	MAIL ADDRESS:	
		STREET 1:		256 E. GRAND AVENUE, SUITE 104
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Helix Acquisition Corp. II
		DATE OF NAME CHANGE:	20210623

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BC Global Opportunities IX LP
		CENTRAL INDEX KEY:			0002013681
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1224

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		ROOM 1210-12, 12/F, NAN FUNG TOWER,
		STREET 2:		NO. 88 CONNAUGHT ROAD CENTRAL, CENTRAL,
		CITY:			HONG KONG
		STATE:			K3
		ZIP:			00000
		BUSINESS PHONE:		(852)38954913

	MAIL ADDRESS:	
		STREET 1:		OFFICES OF TRICOR SERVICES(BVI) LIMITED,
		STREET 2:		2/F, PALM GROVE HOUSE, PO BOX 3340,
		CITY:			ROAD TOWN, TORTOLA,
		STATE:			D8
		ZIP:			VG1110
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002013681</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/04/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001869105</issuerCik>
        <issuerName>BridgeBio Oncology Therapeutics, Inc.</issuerName>
        <issuerCusip>107924102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>256 E. GRAND AVENUE, SUITE 104</com:street1>
          <com:city>SOUTH SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94080</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>BC Global Opportunities IX LP</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>D8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>4365747.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>4365747.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4365747.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.5</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>BC General Partner, LP</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>D8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>4365747.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>4365747.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4365747.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.5</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>Comprise of shares of Common Stock held by BC Global Opportunities IX LP, of which BC General Partner, LP is the general partner.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>BC Capital Management Limited</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>D8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>4365747.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>4365747.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4365747.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.5</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>Comprised of shares of Common Stock held by BC General Partner, LP, of which BC Capital Management Limited is the general partner.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Tan Kuangming</reportingPersonName>
      <citizenshipOrOrganization>D8</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>4365747.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>4365747.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4365747.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>5.5</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Comprised of shares of Common Stock held by BC Global Opportunities IX LP.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>BridgeBio Oncology Therapeutics, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO, CALIFORNIA, 94080</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>BC Global Opportunities IX LP, BC General Partner, LP, BC Capital Management Limited, Tan Kuangming</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>BC Global Opportunities IX LP, BC General Partner, LP, BC Capital Management Limited, Vistra (BVI) Limited of Vistra Corporate Services Centre, Wickhams Cay Il, Road Town, Tortola, VG1110, British Virgin Islands

Tan Kuangming
Room 1202-07, 12/F, Nan Fung Tower,
No. 88 Connaught Road Central,
Central, Hong Kong</principalBusinessOfficeOrResidenceAddress>
        <citizenship>C Global Opportunities IX LP, BC General Partner, LP, BC Capital Management Limited, Citizenship: British Virgin Islands

Tan Kuangming, Citizenship: Hong Kong</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>BC Global Opportunities IX LP - 4,365,747 shares
BC General Partner, LP - 4,365,747 shares
BC Capital Management Limited - 4,365,747 shares
Tan Kuangming - 4,365,747 shares</amountBeneficiallyOwned>
        <classPercent>BC Global Opportunities IX LP - 5.51%
BC General Partner, LP - 5.51%
BC Capital Management Limited - 5.51%
Tan Kuangming - 5.51%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>All Reporting Persons - 0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>BC Global Opportunities IX LP - 4,365,747
BC General Partner, LP - 4,365,747
BC Capital Management Limited - 4,365,747
Tan Kuangming - 4,365,747</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>All Reporting Persons - 0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>BC Global Opportunities IX LP - 4,365,747
BC General Partner, LP - 4,365,747
BC Capital Management Limited - 4,365,747
Tan Kuangming - 4,365,747</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>BC Global Opportunities IX LP</reportingPersonName>
      <signatureDetails>
        <signature>Freeman Szeto</signature>
        <title>Operation Manager</title>
        <date>09/04/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>BC General Partner, LP</reportingPersonName>
      <signatureDetails>
        <signature>Freeman Szeto</signature>
        <title>Operation Manager</title>
        <date>09/04/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>BC Capital Management Limited</reportingPersonName>
      <signatureDetails>
        <signature>Freeman Szeto</signature>
        <title>Operation Manager</title>
        <date>09/04/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Tan Kuangming</reportingPersonName>
      <signatureDetails>
        <signature>Tan Kuangming</signature>
        <title>Director</title>
        <date>09/04/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
